Profile picture

Ms Kathrine Kold Soerensen

North Zealand University Hospital, Copenhagen (Denmark)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Cardiovascular outcomes in sustained use of glucagon like peptide inhibitors: a trial inspired population vs. a broad population
Presentation
Cardiovascular outcomes in sustained use of glucagon like peptide inhibitors: a trial inspired population vs. a broad population
Read more
GLP1-RA versus DPP4 inhibitors on cardiovascular outcomes: A three-year real-world analysis
Presentation
GLP1-RA versus DPP4 inhibitors on cardiovascular outcomes: A three-year real-world analysis
Read more
GLP1-RA versus metformin as first-line therapy for achieving glycemic control and risk-factor management - a one-year nationwide cohort study
Presentation
GLP1-RA versus metformin as first-line therapy for achieving glycemic control and risk-factor management - a one-year nationwide cohort study
Read more

ESC 365 is supported by

novartis Explore sponsored resources